D. E. Shaw & Co., Inc. Evolus, Inc. Transaction History

D. E. Shaw & Co., Inc.

$100 Billion
Q1 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Evolus, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 877,061 shares of EOLS stock, worth $8.68 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

877,061

Previous 848,176 3.41%

Holding current value

$8.68 Million

Previous $9.36 Million 12.69%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$9.47 - $15.04 $273,540 - $434,430	28,885 Added 3.41%	877,061 $10.6 Million
Q4 2024 Feb 14, 2025	SELL	$10.84 - $17.45 $1.32 Million - $2.13 Million	-122,094 Reduced 12.58%	848,176 $9.36 Million
Q3 2024 Nov 14, 2024	BUY	$10.66 - $17.48 $1.06 Million - $1.73 Million	99,172 Added 11.38%	970,270 $15.7 Million
Q2 2024 Aug 14, 2024	SELL	$10.45 - $13.76 $1.11 Million - $1.47 Million	-106,480 Reduced 10.89%	871,098 $9.45 Million
Q1 2024 May 15, 2024	BUY	$9.99 - $14.91 $2.69 Million - $4.01 Million	269,040 Added 37.97%	977,578 $13.7 Million
Q4 2023 Feb 14, 2024	BUY	$7.6 - $10.53 $1.63 Million - $2.26 Million	214,857 Added 43.52%	708,538 $7.46 Million
Q3 2023 Nov 14, 2023	BUY	$7.15 - $10.2 $2.39 Million - $3.42 Million	334,829 Added 210.78%	493,681 $4.51 Million
Q2 2023 Aug 14, 2023	SELL	$7.23 - $10.52 $170,273 - $247,756	-23,551 Reduced 12.91%	158,852 $1.15 Million
Q1 2023 May 15, 2023	SELL	$7.81 - $11.05 $809,155 - $1.14 Million	-103,605 Reduced 36.22%	182,403 $1.54 Million
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.95 $243,515 - $334,273	-37,349 Reduced 11.55%	286,008 $2.15 Million
Q3 2022 Nov 14, 2022	SELL	$7.76 - $13.72 $1.72 Million - $3.05 Million	-221,969 Reduced 40.7%	323,357 $2.6 Million
Q2 2022 Aug 15, 2022	SELL	$10.22 - $13.94 $1.19 Million - $1.63 Million	-116,765 Reduced 17.64%	545,326 $6.33 Million
Q1 2022 May 16, 2022	SELL	$5.22 - $11.78 $199,482 - $450,172	-38,215 Reduced 5.46%	662,091 $7.43 Million
Q4 2021 Feb 14, 2022	BUY	$5.37 - $8.38 $226,007 - $352,689	42,087 Added 6.39%	700,306 $4.56 Million
Q3 2021 Nov 15, 2021	BUY	$7.36 - $13.67 $1.16 Million - $2.16 Million	157,853 Added 31.55%	658,219 $5.02 Million
Q2 2021 Aug 16, 2021	BUY	$8.42 - $13.96 $2.84 Million - $4.71 Million	337,068 Added 206.41%	500,366 $6.33 Million
Q1 2021 May 17, 2021	BUY	$3.2 - $16.51 $485,161 - $2.5 Million	151,613 Added 1297.5%	163,298 $2.12 Million
Q3 2018 Nov 14, 2018	BUY	$17.31 - $29.82 $202,267 - $348,446	11,685 New	11,685 $218,000

Others Institutions Holding EOLS

# of Institutions

187

Shares Held

52M

Call Options Held

142K

Put Options Held

58.4K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $555M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account